XML 38 R30.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2023
STOCK-BASED COMPENSATION  
Schedule of stock-based compensation expense

Stock-based compensation expense included in the Company’s condensed consolidated statements of operations and comprehensive income (loss) was as follows (in thousands):

​

​

​

​

​

​

​

​

​

Three months ended March 31, 

​

​

2023

    

2022

Stock options, restricted stock units and restricted common stock

​

$

6,643

​

$

4,784

Earn-Out Shares

​

​

949

​

​

8,122

Total stock-based compensation

​

$

7,592

​

$

12,906

​

​

​

​

​

​

​

Research and development

​

$

2,750

 

$

3,841

General and administrative

​

 

4,905

 

​

9,065

Restructuring

​

​

(63)

​

​

—

Total stock-based compensation

​

$

7,592

​

$

12,906

​

Schedule of options activity

A summary of stock option activity for employee and nonemployee awards during the three months ended March 31, 2023 is presented below:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

​

​

​

​

​

​

​

​

Average

​

Aggregate

​

​

​

​

Weighted-

​

Remaining

​

Intrinsic

​

​

​

​

Average

​

Contractual

​

Value

​

​

​

​

Exercise

​

Term

​

(in

​

    

Options

    

    Price

    

(years)

    

    thousands)

Outstanding at December 31, 2022

​

43,380,290

​

$

3.52

​

​

​

​

​

Granted

​

—

​

​

—

​

​

​

​

​

Exercised

​

(199,109)

​

​

0.64

​

​

​

​

​

Cancelled/forfeited

​

(2,917,884)

​

​

3.63

​

​

​

​

​

Outstanding at March 31, 2023

 

40,263,297

​

$

3.53

 

8.57

​

$

3,772

Vested at March 31, 2023

 

14,098,417

​

$

3.13

 

8.25

​

$

2,252

Vested and expected to vest at March 31, 2023

 

40,263,297

​

$

3.53

 

8.57

​

$

3,772

​

Schedule of restricted stock and restricted stock units activity

​

​

​

​

​

​

​

​

​

​

​

Weighted-

​

​

​

​

Average

​

​

Number of

​

 Grant Date

​

    

Units

    

 Fair Value

Outstanding at December 31, 2022

​

825,707

​

$

2.15

Granted

​

—

​

​

—

Vested

​

—

​

​

—

Forfeited

​

—

​

​

—

Outstanding at March 31, 2023

 

825,707

​

$

2.15

​

A summary of the Company’s restricted common stock activity and related information during the three months ended March 31, 2023 is as follows:

​

​

​

​

​

​

​

    

​

    

Weighted-

​

​

​

​

Average

​

​

Number of

​

 Grant Date

​

    

 Shares

    

 Fair Value

Unvested restricted common stock at December 31, 2022

​

9,827,819

​

$

0.15

Granted

​

—

​

​

—

Forfeited

​

(1,343,341)

​

​

0.92

Vested

​

(1,956,530)

​

​

0.07

Unvested restricted common stock at March 31, 2023

 

6,527,948

 

$

0.03

​

Schedule of earn-out shares activity

The following table summarizes the activity associated with Earn-Out Shares accounted for pursuant to ASC 718 during the three months ended March 31, 2023:

​

​

​

​

​

​

​

​

​

​

Weighted-

​

​

​

​

Average

​

​

​

​

Grant Date Fair Value

​

    

Number of Shares

    

Per Share

Outstanding at December 31, 2022

​

7,377,888

​

$

5.67

Granted

​

38,220

​

​

0.17

Forfeited

​

(296,685)

​

​

5.73

Outstanding at March 31, 2023

 

7,119,423

​

$

5.64

​